EPHA2 and cancer: Moreover, whether KRAS status or mutations of other cancer driver genes in CRC patients (TCGA database) might have led to lack of CEACAM5 interaction with the other studied genes (CEACAM1, CEACAM6 and EPHA2) will need further investigation.